Literature DB >> 16958049

RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin.

S Garcia-Filipe1, V Barbier-Chassefiere, C Alexakis, E Huet, D Ledoux, M E Kerros, E Petit, D Barritault, J P Caruelle, P Kern.   

Abstract

Burn-related skin fibrosis leads to loss of tissue function and hypertrophic scar formation with damaging consequences for the patient. There is therefore a great need for an efficient agent to treat burned skin. We report that ReGeneraTing Agent (RGTA) reduces burn-induced skin alteration. The tissue-regenerating effect of RGTA OTR4120 was evaluated after 1-6 days and after 10 months in a rat skin burn model. This effect was also examined in vitro using fibroblasts isolated from control and 6-day-old burned skins. We measured production of dermal collagen I, III, and V and activities of metalloproteinases 2 and 9 (MMP-2 and MMP-9). Ratio of collagen III over collagen I production increased 6 days after the burn, because of a decrease in collagen I production. After 10 months, ratio of collagen III over collagen I in burn sites was still increased compared with control skin, because of an increase in collagen III production. Both abnormalities were corrected by OTR4120. OTR4120 increased pro- and active MMP-2 and MMP-9, compared with healthy and burned controls and therefore accelerated remodeling. Similar data were obtained with cultured fibroblasts from healthy and burned skins. OTR4120 enhanced healing in short- and long-term after burns, reducing the formation of fibrotic tissue, and then represents a potential agent to improve burned skin healing. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16958049     DOI: 10.1002/jbm.a.30874

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  14 in total

1.  Regenerating matrix-based therapy for chronic wound healing: a prospective within-subject pilot study.

Authors:  Suzanne L Groah; Alexander Libin; Miriam Spungen; Kim-Loan Nguyen; Earthaleen Woods; Marjan Nabili; Jessica Ramella-Roman; Denis Barritault
Journal:  Int Wound J       Date:  2010-11-16       Impact factor: 3.315

Review 2.  Stewart-Bluefarb syndrome: review of the literature and case report of chronic ulcer treatment with heparan sulphate (Cacipliq20®).

Authors:  Shady Hayek; Bishara Atiyeh; Elias Zgheib
Journal:  Int Wound J       Date:  2013-04-05       Impact factor: 3.315

3.  Matrix regeneration agents improve wound healing in non-stressed human corneal epithelial cells.

Authors:  A Robciuc; R P J Arvola; M Jauhiainen; J M Holopainen
Journal:  Eye (Lond)       Date:  2017-12-22       Impact factor: 3.775

4.  Refractory sickle cell leg ulcer: is heparan sulphate a new hope?

Authors:  Shady Hayek; Saad Dibo; Joe Baroud; Amir Ibrahim; Denis Barritault
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

5.  Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

Authors:  Sophie M Thompson; Marilyn G Connell; Toin H van Kuppevelt; Ruoyan Xu; Jeremy E Turnbull; Paul D Losty; David G Fernig; Edwin C Jesudason
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

6.  Diabetes-impaired wound healing is improved by matrix therapy with heparan sulfate glycosaminoglycan mimetic OTR4120 in rats.

Authors:  Miao Tong; Bastiaan Tuk; Peng Shang; Ineke M Hekking; Esther M G Fijneman; Marnix Guijt; Steven E R Hovius; Johan W van Neck
Journal:  Diabetes       Date:  2012-06-20       Impact factor: 9.461

Review 7.  Oxidative stress to the cornea, changes in corneal optical properties, and advances in treatment of corneal oxidative injuries.

Authors:  Cestmir Cejka; Jitka Cejkova
Journal:  Oxid Med Cell Longev       Date:  2015-03-11       Impact factor: 6.543

Review 8.  Heparin-Mimicking Polymers: Synthesis and Biological Applications.

Authors:  Samantha J Paluck; Thi H Nguyen; Heather D Maynard
Journal:  Biomacromolecules       Date:  2016-10-14       Impact factor: 6.988

Review 9.  RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients.

Authors:  Denis Barritault; Marie Gilbert-Sirieix; Kim Lee Rice; Fernando Siñeriz; Dulce Papy-Garcia; Christophe Baudouin; Pascal Desgranges; Gilbert Zakine; Jean-Louis Saffar; Johan van Neck
Journal:  Glycoconj J       Date:  2016-12-07       Impact factor: 2.916

10.  A Rapid Response to Matrix Therapy With RGTA in Severe Epidermolysis Bullosa.

Authors:  Ali Al Malaq; Denis Barritault
Journal:  Eplasty       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.